Close
Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
08:00-09:15
  • GBCC-SSO Joint Session
  • Venue:  RM 3(Walker Hall 1)
Moderators
  • Sang Uk Woo
     (Korea Univ. Guro Hospital, Korea)
  • Christine Laronga
     (Moffitt Cancer Center, U.S.A.)
Speakers
  • Clinical Trials of Breast Cancer Surgery in Korea & Introduction to KBCSG
    Han-Byoel Lee
     (Seoul National Univ. Hospital, Korea)
  • Trials in Breast Cancer Lead by Surgical Oncologists in the US & Introduction to SSO
    Jennifer Plichta
     (Duke Univ. Medical Center, U.S.A.)
Panelist
  • Discussion About Potential Collaborative Programs and Studies Between SSO and KBCS
    Jeong Eon Lee
     (Samsung Medical Center, Korea)
08:30-09:15
  • Satellite Symposium 2: 
    Novartis
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Nam Sun Paik
     (Pohang SM Christianity Hospital, Korea)
Speakers
  • The Evolving Landscape of HR+/HER2- Breast Cancer Treatment
    Aditya Bardia
     (Massachusetts General Hospital, U.S.A.)
09:30-10:15
  • Plenary Lecture 3
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Joon Jeong
     (Gangnam Severance Hospital, Korea)
Speakers
  • Defining Today’s Surgical Standards of Care in Patients with Breast Cancer
    Walter Paul Weber
     (Univ. Hospital Basel, Switzerland)
10:30-11:45
  • Symposium 3: 
    Translational Approach through Cancer Genomics and Biology
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Jeong-Yeon Lee
     (Hanyang Univ. College of Medicine, Korea)
  • Alex Swarbrick
     (Garvan Institute of Medical Research, Australia)
Speakers
  • Genomic Amplification Linked to Therapeutic Resistance in Breast Cancer
    Jeong-Yeon Lee
     (Hanyang Univ. College of Medicine, Korea)
  • Immune Biomarker and Ecosystem in Breast Cancer
    Alex Swarbrick
     (Garvan Institute of Medical Research, Australia)
  • Genomics Related to Treatment After CDK4/6 Inhibitors in Hormone Receptor Positive Breast Cancer
    Rinath Jeselsohn
     (Dana-Farber Cancer Institute, U.S.A.)
  • Panel Discussion 5: 
    Obesity, Life Style Modification, and Exercise
  • Venue:  RM 2(Vista 3)
Moderators
  • Byung Ho Son
     (ASAN Medical Center, Korea)
  • Pamela Goodwin
     (Lunenfeld Tanenbaum Research Institute at Sinai Health System, Univ. of Toronto, Canada)
Speakers
  • The Role of Weight Loss and Metformin in the Adjuvant Treatment of Breast Cancer
    Pamela Goodwin
     (Lunenfeld Tanenbaum Research Institute at Sinai Health System, Univ. of Toronto, Canada)
  • Life Style Modification of Breast Cancer Survivors
    Hyun Jo Youn
     (Jeonbuk National Univ. Hospital, Korea)
  • Physical Activity Intervention in Women with Breast Cancer
    Justin Y. Jeon
     (Yonsei Cancer Center, Korea)
  • Education Session 5: 
    Update in the Management of Adverse Events
  • Venue:  RM 3(Walker Hall 1)
Moderators
  • Keun Seok Lee
     (National Cancer Center, Korea)
  • Toshiaki Saeki
     (Saitama Medical Univ. International Medical Center, Japan)
Speakers
  • Management of Cardiotoxicity of Breast Cancer
    Woo-Baek Chung
     (Seoul St. Mary’s Hospital, Korea)
  • Management of AIMSS (Aromatase-inhibitor-associated Musculoskeletal Syndrome)
    Eun Joo Yang
     (Daerim St. Mary's Hospital, Korea)
  • Management of Chemotherapy Induced Nausea and Vomiting (CINV)
    Toshiaki Saeki
     (Saitama Medical Univ. International Medical Center, Japan)
  • Oral Presentation 3
  • Venue:  RM 4(Walker Hall 2)
Moderators
  • Yongsik Jung
     (Ajou Univ. Hospital, Korea)
  • Kyung-Hun Lee
     (Seoul National Univ. Hospital, Korea)
  • ABCN Business Meeting (Invited Only)
  • Venue:  RM 5(Art Hall)
Moderators
  • Sung-Bae Kim
     (ASAN Medical Center, Korea)
Speakers
  • Legacy of GBCC: Beyond Asia Towards the World, New Era of GBCC
    Joon Jeong
     (Gangnam Severance Hospital, Korea)
  • Sharing Wisdom, Sharing Strength - Mentorship and International Collaboration
    Philip Poortmans
     (Iridium Netwerk & Univ. of Antwerp, Belgium)
  • Knowledge, Attitude, Practice Behaviors and Barriers for Fertility Preservation 
    Heejeong Kim
     (ASAN Medical Center, Korea)
12:00-12:45
  • Plenary Lecture 4
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Kyung Hwan Shin
     (Seoul National Univ. Hospital, Korea)
Speakers
  • Optimising Radiation Therapy in Early Stage Breast Cancer
    Philip Poortmans
     (Iridium Netwerk & Univ. of Antwerp, Belgium)
13:00-13:45
  • Satellite Symposium 3: 
    Roche Korea
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Kyung Hae Jung
     (ASAN Medical Center, Korea)
Speakers
  • Transforming the Treatment Journey for HER2+ Breast Cancer Patients
    Joyce O'Shaughnessy
     (Baylor Univ. Medical Center, U.S.A.)
14:00-14:45
  • Plenary Lecture 5
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Sung-Bae Kim
     (ASAN Medical Center, Korea)
Speakers
  • Presurgical Window Studies for Drug Development, Studies of Resistance and Patient Management
    Mitch Dowsett
     (Royal Marsden Hospital, UK)
15:00-16:15
  • Symposium 4: 
    Immunotherapy in Breast Cancer
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Kyung Hae Jung
     (ASAN Medical Center, Korea)
  • Peter Schmid
     (Bart's Cancer Institute, UK)
Speakers
  • Current Status of Immunotherapy: Where are We?
    Hiroji Iwata
     (Aichi Cancer Center Hospital, Japan)
  • Biomarker for Immunotherapy: What is the Best?
    Peter Schmid
     (Bart's Cancer Institute, UK)
  • Challenge for Immunotherapy in Breast Cancer: Hot or Cold
    Sherene Loi
     (Univ. of Melbourne, Australia)
  • Panel Discussion 6: 
    Updates of Combined Management for Metastatic Breast Cancer
  • Venue:  RM 2(Vista 3)
Moderators
  • Young-Jin Suh
     (The Catholic Univ. of Korea, St. Vincent's Hospital, Korea)
  • Takayuki Ueno
     (The Cancer Institute Hospital of JFCR, Japan)
Speakers
  • Timing of Breast Surgery in Metastatic Breast Cancer: Is It Really Necessary to Perform Palliative Mastectomy?
    Sung Gwe Ahn
     (Gangnam Severance Hospital, Korea)
  • Current Status of Locoregional Therapy in ER+/HER2- Oligometastatic Breast Cancer
    Takayuki Ueno
     (The Cancer Institute Hospital of JFCR, Japan)
  • Role of Stereotactic Ablative Radiotherapy in Oligometastatic Breast Cancer
    Steven J. Chmura
     (Univ. of Chicago, U.S.A.)
  • Education Session 6: 
    Psychologic Problem Management
  • Venue:  RM 3(Walker Hall 1)
Moderators
  • Jung Han Yoon
     (Chonnam National Univ. Hwasun Hospital, Korea)
  • Hideko Yamauchi
     (St. Luke's International Hospital, Japan)
Speakers
  • Psychological Interventions on Fatigue of Breast Cancer Patients
    Eun-Jung Shim
     (Pusan National Univ. Hospital, Korea)
  • Assessment and Management of Insomnia
    Seockhoon Chung
     (ASAN Medical Center, Korea)
  • Standard of Care for Breast Cancer Distress
    Hideko Yamauchi
     (St. Luke's International Hospital, Japan)
  • Oral Presentation 4
  • Venue:  RM 4(Walker Hall 2)
Moderators
  • Hyeong-Gon Moon
     (Seoul National Univ. Hospital, Korea)
  • Zisun Kim
     (Soonchunhyang Univ. Hospital Bucheon, Korea)
  • Nursing Session 1 (Korean): 
    Challenges of Nursing Care Beyond a Pandemic
  • Venue:  RM 5(Art Hall)
Moderators
  • Eun-Young Jun
     (Daejeon Univ., Korea)
  • Hye Sung Moon
     (Ewha Womans Univ. Mokdong Hospital, Korea)
Speakers
  • The Education for Breast Cancer Patients During Covid Pandemic
    Jiyoung Choi
     (Seoul National Univ. Bundang Hospital, Korea)
  • Supportive Care Post Pandemic Breast Cancer Patients
    In Jeong Cho
     (Wonju Severance Christian Hospital, Korea)
  • Experience of Education for Breast Cancer Patients post COVID-19
    Nayeon Kim
     (Samsung Medical Center, Korea)
16:30-17:45
  • Symposium 5: 
    Recent Updates for Surgery After Neoadjuvant Chemotherapy
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Emiel Rutgers
     (Netherlands Cancer Institute, Netherlands)
  • Sung Yong Kim
     (Soonchunhyang Univ. Hospital Cheonan, Korea)
Speakers
  • De-escalation of Axillary Surgery After NACT
    Jeong Eon Lee
     (Samsung Medical Center, Korea)
  • De-escalation of Breast Surgery After NACT
    Peter C. Dubsky
     (Hirslanden Klinik St. Anna, Switzerland)
  • Can We Select Patients in Whom We Can Forego Any Axillary Treatment after up front Chemotherapy?
    Emiel Rutgers
     (Netherlands Cancer Institute, Netherlands)
  • Panel Discussion 7: 
    How to Apply Multigene Panel for ER+ EBC- Asia vs. Western
  • Venue:  RM 2(Vista 3)
Moderators
  • Yeon Hee Park
     (Samsung Medical Center, Korea)
  • Janice Tsang
     (The Univ. of Hong Kong, Hong Kong)
Speakers
  • Multigene Assays: What Evidence Do We Have?
    Janice Tsang
     (The Univ. of Hong Kong, Hong Kong)
  • Is There any Difference in Multigene Assays Developed from Asian and Western Countries?
    Han-Byoel Lee
     (Seoul National Univ. Hospital, Korea)
  • Practical Application of Multigene Assays in Real Clinical Setting (Asia vs. Western)
    Rebecca Dent
     (National Cancer Centre Singapore, Singapore)
  • Education Session 7: 
    Tailored Adjuvant Endocrine Therapy in ER+ Breast Cancer
  • Venue:  RM 3(Walker Hall 1)
Moderators
  • Se Jeong Oh
     (The Catholic Univ. of Korea, Incheon St. Mary's Hospital, Korea)
  • Maria-Joao Cardoso
     (Champalimaud Foundation, Portugal)
Speakers
  • Optimal Treatment Options for High Risk ER+ Breast Cancer
    Maria-Joao Cardoso
     (Champalimaud Foundation, Portugal)
  • Extended Endocrine Therapy, Optimal Duration and Sequence
    Sung Hoon Sim
     (National Cancer Center, Korea)
  • Ovarian Suppression with/without Adjuvant Chemotherapy in High-risk Premenopausal Patients
    Shin-Cheh Chen
     (Chang Gung Memorial Hospital, Taiwan)
  • Oral Presentation 5
  • Venue:  RM 4(Walker Hall 2)
Moderators
  • Min Sung Chung
     (Hanyang Univ. Seoul Hospital, Korea)
  • Kyubo Kim
     (Ewha Womans Univ. Mokdong Hospital, Korea)
  • Nursing Session 2 (Korean): 
    Return to Life Beyond Cure Among Young Women
  • Venue:  RM 5(Art Hall)
Moderators
  • Mi Young Kang
     (Daerim St. Mary's Hospital, Korea)
  • Soo Hyun Kim
     (Inha Univ., Korea)
Speakers
  • Working Young Women with Breast Cancer: For a Life that Makes Me Who I Am
    Ka Ryeong Bae
     (National Cancer Center, Korea)
  • Human Flourishing in Adolescents and Young Adults with Cancer
    Eunji Cho
     (Vanderbilt Univ., Korea)
  • Fertility Preservation for Women with Breast Cancer
    Jeehee Han
     (Chung-Ang Univ. College of Nursing, Korea)
18:00-18:45
  • Satellite Symposium 4: 
    Lilly Korea
  • Venue:  RM 1(Vista 1+2)
Moderators
  • Kweon Cheon Kim
     (Chosun Univ. Hospital, Korea)
Speakers
  • Verzenio, Potent CDK4/6 Inhibitor, How to Optimize HR+/HER2- mBC Patient with CDK4/6 Inhibitors
    Tomoyuki Aruga
     (Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan)



Global Breast Cancer Conference Secretariat

Partner I INTERCOM Convention Services, Inc. (Core PCO)

TOP